Research project investigating xantholysin, a lipopeptide produced by Pseudomonas mosselii, as a biocontrol agent against Fusarium oxysporum crop pathogens. The study aims to determine whether xantholysin's antifungal activity works through membrane permeabilization and ionic leakage, supporting development of natural crop protection solutions.
This research project investigates the molecular mechanism of xantholysin, a lipopeptide produced by Pseudomonas mosselii, as a potential biocontrol agent against multiple formae speciales of Fusarium oxysporum that infect economically important crops. The study seeks to determine whether xantholysin's antifungal activity operates through membrane permeabilization, causing ionic leakage and cell death in a dose-dependent manner. By elucidating the molecular target of this lipopeptide, the research aims to support the development of natural, biologically-based crop protection strategies that could reduce reliance on conventional fungicides.
Research approach:
Key scientific premise:
This project is in early-stage research. The hypothesis is based on prior studies demonstrating antifungal activity, but the specific molecular target of xantholysin has not yet been investigated. The research team is seeking sponsorship to fund the purification of xantholysin and the execution of membrane permeabilization and ionic leakage assays. The proposed study is expected to take approximately one year to complete, and will provide foundational mechanistic understanding needed to advance xantholysin as a candidate biocontrol product for agricultural applications.
UC Davis is a comprehensive public research university in Northern California, combining a land-grant heritage with an integrated academic health system and a veterinary teaching hospital. Industry engages through co-located clinical and translational facilities in Sacramento, a campus-adjacent research park, pilot-scale food and bioprocessing facilities, and a statewide extension network for field-to-market deployment. Proximity to the Bay Area and California's Central Valley enables rapid collaboration with startups and established enterprises, while corporate relations staff streamline access to faculty, talent, and core labs. Research is supported by competitive federal funding from agencies such as NIH, NSF, USDA, and DOE. A dedicated technology transfer office and venture support programs provide IP management, licensing, and startup formation pathways for industry partnerships.